PROVIDENCE — Rhode Island Hospital has joined phase four of the $40 million Alzheimer’s Disease Neuroimaging Initiative, an international clinical trial studying the rate of brain function changes as people age past 55, which will guide Alzheimer’s treatment research. The trial, mainly funded by the National Institutes of Health at $40 million, with up to…
Want More Free?
To access 2 more articles, please log in or register for free.
Registered users get access to a limited number of free articles every month.